HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo
Biotron (ASX:BIT) has angered shareholders on HotCopper on Friday as the results of its latest COVID-facing trial come up dusty.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
AIC | AIC: ASIC appoints Morgan Stanley to sell shares in RIS | PRICE SENSITIVE | 07/07/15 | |
NCM +AIC | Newcrest reaches settlement with ASIC | PRICE SENSITIVE | 18/06/14 | |
AIC +ASX | Trading Halt | PRICE SENSITIVE | 15/02/11 | |
AIC AIC: ASIC appoints Morgan Stanley to sell shares in RIS | |||
07/07/15 | PRICE SENSITIVE | 145.74KB | |
NCM +AIC Newcrest reaches settlement with ASIC | |||
18/06/14 | PRICE SENSITIVE | 464.88KB | |
AIC +ASX Trading Halt | |||
15/02/11 | PRICE SENSITIVE | 46.49KB | |